drugset / Trial / NCT00290420
Prevention of P. Vivax Malaria During Pregnancy in Bolivia
Phase 4
Withdrawn
Research Institute for Development
Instituto Nacional de Laboratorios de Salud (INLASA) · collabMinistry of Health, Bolivia · collabPan American Health Organization · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to determine which, between weekly prophylaxis or malaria attack treatment, both by chloroquine, is the most appropriate way to protect women and foetus from P. vivax malaria infection during pregnancy.
Timeline
- Start
- 2006-03
- Primary completion
- 2007-11
- Completion
- 2007-11
Outcome
Outcome not reported
Stopped: “important delays and malaria season missed, due to political changes”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chloroquine | Small molecule | — | — |